ACUTAAS.NS NSE
Acutaas Chemicals Ltd.
1W: -2.7%
1M: +0.7%
3M: -13.5%
YTD: +55.9%
1Y: +143.0%
₹3,200.00 ($33.23)
-79.40 (-2.42%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$13.4B
+33.0% ▲
Gross Profit
$6.2B
+36.3% ▲
Operating Income
$4.4B
+19.8% ▲
Net Income
$3.6B
+124.5% ▲
EPS (Diluted)
$43.37
+118.9% ▲
EBITDA
$4.8B
+107.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2024 | FY2026 |
|---|---|---|
| Revenue | $10.1B | $13.4B |
| YoY Growth | — | +33.0% |
| Cost of Revenue | $7.3B | $7.2B |
| Gross Profit | $2.7B | $6.2B |
| Gross Margin | 27.1% | 46.3% |
| R&D Expenses | $0 | $0 |
| SG&A Expenses | $353M | $1.8B |
| Operating Expenses | $653M | $1.8B |
| Operating Income | $2.1B | $4.4B |
| Operating Margin | 20.6% | 33.2% |
| Interest Expense | $62M | $33M |
| Income Before Tax | $2.2B | $4.8B |
| Tax Expense | $557M | $1.3B |
| Net Income | $1.6B | $3.6B |
| Net Margin | 15.8% | 26.6% |
| EPS (Diluted) | $19.81 | $43.37 |
| EBITDA | $2.5B | $4.8B |
| Shares Outstanding | 80M | 82M |